The global anastomosis devices market revenue is expected to reach USD 5,535.1 million by 2030, exhibiting a CAGR of 8.5% during 2022–2030. The primary forces behind the industrial growth include the rising incidences of target ailments, the increasing number of surgical procedures, and the surging preference for minimally invasive procedures. Moreover, high expenditure on research and development by various companies to come up with highly innovative and technologically enhanced products is expected to further propel the growth of the industry.
These devices are essential in surgical procedures since chronic diseases are becoming more prevalent. As a result, the demand for these gadgets will rise, due to the numerous advantages offered by them, including less operating time and reduced exposure to anesthesia. Also, risks that arise during surgical procedures can be considerably decreased by using such modern tools.
There has been a significant boom in the geriatric population, and this surge will contribute to the industry’s success because of the propensity of older people to develop chronic illnesses, such as high blood pressure, obesity, cancer, and heart diseases, due to the inactivity in such population group. This is why they have a higher risk to develop such diseases in comparison to the younger generation.
The hospitals category accounted for the largest revenue share, of nearly 60%, in 2022. As a result of their enhanced patient care, hospitals have experienced profitable expansion. In addition, an increase in the number of patients visiting hospitals due to adequate reimbursement options and easy access to treatment, the availability of qualified healthcare workers, a rise in the number of hospitals, and the presence of technologically advanced facilities in hospitals are all contributing to the growth of the market in this category.
Whereas, the ambulatory care facilities and clinics category is projected to grow at the highest CAGR, around 10%, in the coming years. This can be ascribed to the growing inclination for outpatient care, which is more affordable and does not require a stay. In the upcoming years, it is also predicted that government activities and the accessibility of funds for ambulatory healthcare facilities will drive the industry in this category.
The APAC market is expected to witness the highest CAGR during the forecast period. This can be due to the region's improving economic conditions, the surging healthcare awareness, and the booming elderly population. Aged individuals are more prone to digestive and cardiovascular illnesses, leading to the increasing demand for anastomosis systems.
Moreover, a higher proportion of CVD deaths occurred in lower socioeconomic groups. In developing countries of the region, cardiac disease deaths make up over three-quarters of all deaths. Additionally, in underdeveloped countries, it is projected to kill more people in 2030 than infectious, nutritional, maternal, and perinatal disorders combined.
Furthermore, the regional market is expected to be driven by the surging demand for such products, the growing interest of companies in expanding their presence in APAC nations, the rising research and development activities, and the surging healthcare spending in the region.
Europe accounts for the second-largest market share worldwide. This is because of the constant rise in the number of senior citizens and their propensity to develop chronic illnesses. Moreover, over half of all fatalities in Europe are caused by CVDs, according to the National Library of Medicine.
Key players in the anastomosis devices market are Johnson & Johnson, Medtronic plc, B. Braun Melsungen AG, Smith & Nephew plc, Becton, Dickinson and Company, CONMED Corporation, Baxter International Inc., Intuitive Surgical Inc., BIOSINTEX, and Meril Life Sciences.